News

Displaying 281 - 300 of 734

In memoriam – Prof Dr Brice De Ruyver

It was with great sadness that the EMCDDA learned this morning of the sudden passing of Prof. Dr. Brice De Ruyver at the age of 62. Professor in criminal law, criminal justice...

Lisbon bridge

Lisbon hosts Second European conference on addictive behaviours and dependencies

Leading international experts in the field of addiction science will meet in Lisbon from 24–26 October 2017.

How to estimate the cost of drug treatment in Europe?

How can we estimate the cost of drug treatment in Europe? This is the question explored in a new EMCDDA report.

International experts to meet in Lisbon to address drugs and road safety

The 3rd International symposium on drug-impaired driving will be held on 23 October in Lisbon.

sewage water

Leading experts to review latest developments in detecting illicit drugs in wastewater

The international conference on wastewater analysis, organised by the SCORE group and the EMCDDA will take place on 26–27 October.

EMCDDA scientific award winners to present at Lisbon Addictions 2017

The acclaimed writers will receive a non-monetary prize and present their articles during the Lisbon Addictions conference.

EMCDDA launches new online resources to support drug policy evaluation

Today, the EMCDDA launches a new package of online resources designed to inform and support those considering, or involved in, drug policy evaluation.

Acryloylfentanyl to be placed under control across the EU

This week, the EU has reacted to serious concerns over the use of the synthetic opioid acryloylfentanyl by deciding to subject it to ‘control measures’ throughout the Union.

Upcoming European guide on health and social responses to drug problems

Health and social responses to drug problems in Europe will be placed in the spotlight in a pioneering new EMCDDA guide to be launched on 24 October during Lisbon Addictions 2017.

EMCDDA signs accord with Swiss Federal Office of Public Health

Europe’s regional monitoring system on drugs is enriched today, thanks to a new working arrangement signed in Lisbon between the EMCDDA and the Federal Office of Public Health of Switzerland.

Washington State Institute reports on cannabis legalisation

As part of the legalisation in Washington State that took effect in July 2014, the state legislature instructed the Washington State Institute of Public Policy (WSIPP) to publish periodic evaluations looking at...

figure edr

Preventing and reducing drug overdoses — a priority for the EMCDDA

International Overdose Awareness Day is an annual event, held on 31 August, to raise awareness of overdose and reduce the stigma of drug-related death. The EMCDDA marks the day by highlighting its...

United States: Legalisation stalls in Vermont and Delaware

As legislators depart for their summer break, in two US states that do not have the ability to pass laws by popular vote, draft laws (‘bills’) for cannabis legalisation have yet to...

#WorldHepatitisDay: EMCDDA joins forces with partners to address viral hepatitis elimination targets

Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day (WHD) to increase awareness and understanding of viral hepatitis and the diseases it causes. Read news...

Gavel

Uruguay: recreational cannabis sales start at pharmacies

On 19 July 2017, sales of cannabis started at pharmacies in Uruguay. This is the final step of operationalising the 2013 law that legalised cannabis consumption and sale to over-18s for recreational...

Sixth European drugs summer school kicks off in Lisbon with record number of students

The sixth European drugs summer school opens today on International day against drug abuse and illicit trafficking with a record number of students.

EMCDDA conference to take stock of achievements as IPA5 project draws to a close

The EMCDDA is organising a conference in Sarajevo today marking the end of a two-year technical cooperation project with beneficiary countries of the Instrument for Pre-Accession Assistance (IPA).

Virus

EMCDDA and ECDC join forces to address the challenge of hepatitis

Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EMCDDA in Lisbon from 12–16 June. The initiative brings together some 100 specialists in the...

EMCDDA highlights growing threats posed by new and established substances

Rising overdose deaths, the availability of new psychoactive substances and the growing health threat of potent synthetic opioids are among the issues highlighted in this year's European Drug Report.

EMCDDA Director and ISCTE-IUL rector

EMCDDA renews accord with ISCTE-IUL

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) will be strengthening their cooperation.